Heart-brain interaction in cardiogenic dementia: pathophysiology and therapeutic potential

Jiaxu Liu1, Guangxu Xiao1,2, Yujuan Liang1

  • 1State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

PubMed

Insights

Cardiovascular diseases can cause cognitive impairment, known as cardiogenic dementia. Understanding heart-brain links and exploring treatments, including herbal medicines, is crucial for improving quality of life, especially in older adults.

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • Cardiovascular and neurologic diseases often require separate treatments, but a growing body of evidence highlights their interconnectedness.
  • Cardiogenic dementia, a form of cognitive impairment stemming from heart dysfunction, is an emerging area of significant research interest.
  • Effective prevention and treatment strategies for cardiogenic dementia are vital for enhancing the quality of life, particularly among aging populations.

Purpose of the Study:

  • To elucidate the relationship between various heart conditions and cognitive function decline.
  • To provide an updated understanding of the pathogenic mechanisms underlying cardiogenic dementia.
  • To review potential therapeutic interventions, with a focus on herbal medicines.

Main Methods:

  • Review of preclinical and clinical studies investigating the link between heart disease and cognitive impairment.
  • Analysis of established and emerging pathogenic pathways of cardiogenic dementia.
  • Exploration of pharmacological treatments, including multicomponent herbal medicines.

Main Results:

  • Cognitive function changes are associated with coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and heart valve disease.
  • Two primary pathogenic mechanisms for cardiogenic dementia are discussed: cerebral hypoperfusion due to reduced cardiac output and cognitive impairment independent of cerebral blood flow changes.
  • Multicomponent herbal medicines show promise as potential treatments for cardiogenic dementia.

Conclusions:

  • Heart disease significantly impacts cognitive function, leading to cardiogenic dementia.
  • Understanding the dual pathogenic mechanisms is key to developing targeted therapies.
  • Herbal medicines represent a promising avenue for the prevention and treatment of cardiogenic dementia.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
660
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
30
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588